To date, clinical studies of DHEA in patients with specific diseases have yielded generally inconclusive results. Most of the studies were open label or had very small samples. Most of the studies ...

The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, reducing glucocorticoid doses while maintaining androstenedione control in ...

It follows a midstage failure for tildacerfont in severe CAH in March, where the drug was unable to demonstrate a reduction in androstenedione levels from baseline at Week 12. At the time, ...

Dehydroepiandrosterone, or DHEA for short, is a hormone that is created by the adrenal gland. This essential hormone, which acts as a precursor to both testosterone and estrogen, plays a key role ...

Dehydroepiandrosterone, also known as DHEA, is a hormone produced by the adrenal glands. It’s instrumental in the production of other vital hormones such as estrogen and testosterone.

The first-of-its-kind study, published this month in the journal Computers in Human Behavior, also showed null movement in the hormones DHEA, cortisol and androstenedione in saliva samples. The ...

Expert Rev Endocrinol Metab. 2012;7(5):555-566. To summarize, all available studies support the possibility that the HPA axis response to neuroendocrine stimuli may be altered only in a subset of ...